SEC Form 4 · accession 0000899243-15-009644
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Tomasi
Officer — See Remarks
Period of report
Dec 8, 2015
Accepted (ET)
Dec 10, 2015 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 8, 2015 | M | 9,156 | $10.9242 | A | 9,156 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (ISO) | $10.9242 | Dec 8, 2015 | M | 9,156 | D | Apr 24, 2015 | Apr 24, 2024 | Common Stock | 9,156 | 17,279 | D |
Remarks
Chief Scientific Officer and Head of Corporate Development